News

HBeAg loss rate was higher in males and older individuals.

In an analysis, low GI/GL dietary patterns resulted in a reduction in HbA1c, compared with control diets with a mean difference of −0.31.

A sickle cell expert discusses the shifting therapeutic landscape as well as a need to rethink hemoglobin level threshold guidelines for patients.

Schizophrenia PRS was linked to increased disorganized symptom dimension scores.

An ongoing study of the IL-17A and IL-17F inhibitor showed patients with moderate to severe plaque psoriasis achieved long-term skin clearance results.

There was not a statistically significant correlation between CDI recurrence and age, gender, previous proton pump inhibitor use, and antibiotic exposure.

Data show 82% of studies reported significant abstinence from psychomotor stimulant use at the end-of-treatment assessment.

There is a need for new antibiotic targets for treating C difficile infections.

For World Breastfeeding Week, a lactation consultant explains Montefiore's care team strategies and guidance to expecting and new mothers.

Brett King, MD, PhD, encourages dermatologists to wait for more clinical data before making any assumptions on the drug class' safety and selectivity.

Avalglucosidase alfa-ngpt is an enzyme replacement therapy that reduces glycogen accumulation.

The new diet program was compared to the existing front-line therapy of exclusive enteral nutrition.

Data show the change in 24-hour ambulatory systolic blood pressure was significant between treatment and control groups with a reduction of 7.1 mm Hg.

More than half of DAA prescriptions were prescribed by specialists like gastroenterologist and infectious disease physicians.

Would mark the first COVID-19 vaccine to gain full FDA approval.

Data show prevalence of pain increased with age in all age groups, while it was lower among men and non-Hispanic Asian adults.

A new follow-up study highlights the efficacy and safety of the daily oral immunotherapy in. younger patient populations.

Data show skeletal muscle relaxant associated with increased risk of fall-related injury (OR 1.28) and all-cause hospitalization (OR 1.11).

The COVID-19 pandemic may have exposed more disparities based on race or ethnicity in ADHD care.

Outlook Therapeutics anticipates submitting a Biologics License Application to the FDA as early as next year.

A new study suggests the Asthma Predictive Index can be used as a simple, noninvasive tool for determining asthma in preschoolers.

A new multi-year study shows that the immunotherapy increases tolerance of peanut products in patients with allergies.

IBD patients were less likely to have diets that regularly include vegetables, cereals, breads, and diary.

Sharon Hrynkow, PhD, joins the Rare Disease Report to discuss the ultra rare and heterogenous lysosomal storage disorder.

The cumulative time to curative treatment failure rates of patients who received DAA were 93.6% and 73.2% at 1 and 3 years, respectively.

Improving health literacy among these individuals may have a significant and positive impact on the transition from pediatric to adult care.

Kelly Chin, MD discusses the recent FDA approval of selexipag IV and breakthroughs in the cardiovascular care space.